PAULA SARGENT: Open Payments
NPI 1164416368 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 21 payments from 10 companies in 2025. Trend: 2023 $461 · 2024 $446 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 8 | $170 |
| Solventum Corporation | 3 | $83 |
| Smith+Nephew, Inc. | 3 | $55 |
| Hydrofera LLC | 1 | $27 |
| Melinta Therapeutics, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| MIMEDX Group, Inc. | 1 | $21 |
| Kerecis Limited | 1 | $20 |
| Advanced Oxygen Therapy Inc. | 1 | $20 |
| PolyNovo North America LLC | 1 | $15 |
Products named: NUZYRA, ACTIV.A.C., COLLAGENASE SANTYL, HYDROFERA BLUE, Kimyrsa, DALVANCE, Kerecis SurgiClose, Topical Oxygen Chamber for extremities.
Industry payments across AR — which companies pay providers there.
